Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristen B Farrell

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Genetics|September 13, 2015
New Regulators of Clathrin-Mediated Endocytosis Identified in Saccharomyces cerevisiae by Systematic Quantitative Fluorescence MicroscopyKristen B Farrell, Caitlin Grossman, Santiago M Di Pietro
Bioconjugate Chemistry|November 15, 2021
Gemcitabine-Ibandronate Conjugate Enables the Bone-Targeted Combination Therapy in Bone Cancer: Synthesis and Efficacy in Combination with DocetaxelKristen B Farrell, Shawn Zinnen, Douglas H Thamm, et al.
Bone Reports|July 12, 2018
Bisphosphonate conjugation for bone specific drug targetingKristen B Farrell, Alexander Karpeisky, Douglas H Thamm, et al.
Traffic (Copenhagen, Denmark)|January 24, 2015
A second Las17 monomeric actin-binding motif functions in Arp2/3-dependent actin polymerization during endocytosisDaniel Feliciano, Thomas O Tolsma, Kristen B Farrell, et al.
Plos One|May 21, 2024
VDX-111 targets proliferative pathways in canine cancer cell linesKristen B Farrell, Sunetra Das, Steven K Nordeen, et al.
Plos One|April 24, 2026
Distinct tumor genomic signatures underlie canine macrophage polarizationRachel V Brady, Sunetra Das, Dawn L Duval, et al.
The Journal of Cell Biology|July 15, 2017
Novel function of a dynein light chain in actin assembly during clathrin-mediated endocytosisKristen B Farrell, Seth McDonald, Andrew K Lamb, et al.
Molecules (Basel, Switzerland)|January 25, 2025
Novel Approaches to Monitor Pharmacokinetics and Metabolism of Gemcitabine-Ibandronate Conjugate in Mice and DogsJost Klawitter, Mckay Easton, Alexander Karpeisky, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2025
Phosphatidylinositol 3-kinase and mechanistic target of rapamycin dualinhibitor, VDC597, as a therapeutic agent for canine osteosarcomaTravis Meuten, Kristen B Farrell, Barbara J Rose, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2023
Parthenolide As a Therapeutic for Disseminated Canine NeoplasmsLisa J Schlein, Samuel A Brill, Rachel V Brady, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Genetics|September 13, 2015
New Regulators of Clathrin-Mediated Endocytosis Identified in Saccharomyces cerevisiae by Systematic Quantitative Fluorescence MicroscopyKristen B Farrell, Caitlin Grossman, Santiago M Di Pietro
Bioconjugate Chemistry|November 15, 2021
Gemcitabine-Ibandronate Conjugate Enables the Bone-Targeted Combination Therapy in Bone Cancer: Synthesis and Efficacy in Combination with DocetaxelKristen B Farrell, Shawn Zinnen, Douglas H Thamm, et al.
Bone Reports|July 12, 2018
Bisphosphonate conjugation for bone specific drug targetingKristen B Farrell, Alexander Karpeisky, Douglas H Thamm, et al.
Traffic (Copenhagen, Denmark)|January 24, 2015
A second Las17 monomeric actin-binding motif functions in Arp2/3-dependent actin polymerization during endocytosisDaniel Feliciano, Thomas O Tolsma, Kristen B Farrell, et al.
Plos One|May 21, 2024
VDX-111 targets proliferative pathways in canine cancer cell linesKristen B Farrell, Sunetra Das, Steven K Nordeen, et al.
Plos One|April 24, 2026
Distinct tumor genomic signatures underlie canine macrophage polarizationRachel V Brady, Sunetra Das, Dawn L Duval, et al.
The Journal of Cell Biology|July 15, 2017
Novel function of a dynein light chain in actin assembly during clathrin-mediated endocytosisKristen B Farrell, Seth McDonald, Andrew K Lamb, et al.
Molecules (Basel, Switzerland)|January 25, 2025
Novel Approaches to Monitor Pharmacokinetics and Metabolism of Gemcitabine-Ibandronate Conjugate in Mice and DogsJost Klawitter, Mckay Easton, Alexander Karpeisky, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2025
Phosphatidylinositol 3-kinase and mechanistic target of rapamycin dualinhibitor, VDC597, as a therapeutic agent for canine osteosarcomaTravis Meuten, Kristen B Farrell, Barbara J Rose, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2023
Parthenolide As a Therapeutic for Disseminated Canine NeoplasmsLisa J Schlein, Samuel A Brill, Rachel V Brady, et al.
Pageof 1